Skip to main content
Caplight Logo









Amai Proteins

Amai Proteins

Private
IsraelFrontier & Industrial Techhttps://amaiproteins.com/

Last Round

Series A

Jan 10, 2023

Total Funding Raised

$135.75M

Company Overview

Amai Proteins is a food technology company that develops novel designer proteins, including its flagship hyper-sweet protein sweelin™, to help the food and beverage industry reduce sugar content.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, ML Platforms, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

sugar substitutesweet proteinsprecision fermentationcomputational protein designAI-CPDAI protein designsugar reductionfood techprotein engineeringalternative proteinsynthetic biologysynbiofood ingredient supplierfood formulationzero-calorie ingredient

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amai Proteins Comparables

Compare Amai Proteins with similar companies based on industry and business-model similarity.

Amai Proteins comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Incredo
83%
Oobli
82%
Naturannova
82%

Amai Proteins Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 10, 2023
Series ADec 2, 2022
Series ASep 6, 2021
SeedApr 1, 2020
SeedApr 11, 2019
Convertible Debt
Feb 1, 2019

Key People

Founding team and executive leadership

Moshe Hukaylo

Chief Financial Officer

Executive Team

Yigal Gezundhait

Chief Production Officer, COO

Executive Team

Amai Proteins Investors

Notable investors and investment history

Amai Proteins investors
InvestorRounds
Geshem PartnersSeries A
Israel Innovation AuthorityConvertible Debt, Seed
Sucden VenturesSeries A
Harrison Co.Series A
Israel Innovation AuthoritySeed
Danone Manifesto VenturesSeries A
Welltech VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 2, 2022

    $100M round led by Conquest Global Ventures VCC.

  • Sep 6, 2021

    $11.3M round with participation from SGInnovate and Dragones Venture Partners.

Amai Proteins Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amai Proteins Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amai Proteins's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range50
Year Founded2016
Last FundingJan 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?